Barclays
THER

Barclays’s THERATECHNOLOGIES INC COM THER Stock Holding History

Barclays’s Portfolio THER Stock Details THER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-9,067
Closed -$23K – 5437
2020
Q4 		$23K Buy
+9,067
New +$23K ﹤0.01% 4653

Other funds holding THER

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Barclays's THER Position: Q1 2021 in Review

Barclays sold out of THERATECHNOLOGIES INC COM (THER) in Q1 2021, closing a stake of 9,067 shares — an estimated $23K sold.

Barclays first reported a position in THER in Q4 2020 and held it in 1 quarter. The position peaked at $23K in Q4 2020. 42 funds tracked by Wall St. Rank hold THER as of Q1 2021.

  • Barclays reported no remaining THERATECHNOLOGIES INC COM position as of Q1 2021 after selling out during the quarter.
  • Barclays sold 9,067 THERATECHNOLOGIES INC COM shares in Q1 2021, an estimated $23K.
  • Barclays first reported a position in THERATECHNOLOGIES INC COM in Q4 2020 and held it in 1 quarter.
  • Barclays's THERATECHNOLOGIES INC COM position peaked at $23K in Q4 2020.
  • 42 funds tracked by Wall St. Rank held THERATECHNOLOGIES INC COM as of Q1 2021.

Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.